BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 38792508)

  • 1. Disease Control and Treatment Satisfaction in Patients with Chronic Spontaneous Urticaria in Japan.
    Fukunaga A; Kishi Y; Arima K; Fujita H
    J Clin Med; 2024 May; 13(10):. PubMed ID: 38792508
    [No Abstract]   [Full Text] [Related]  

  • 2. The Benefit of Complete Response to Treatment in Patients With Chronic Spontaneous Urticaria-CURE Results.
    Kolkhir P; Laires PA; Salameh P; Asero R; Bizjak M; Košnik M; Dissemond J; van Doorn M; Hawro T; Kasperska-Zajac A; Zajac M; Kocatürk E; Peter J; Parisi CAS; Ritchie CA; Kulthanan K; Tuchinda P; Fomina D; Kovalkova E; Khoshkhui M; Kouzegaran S; Papapostolou N; Du-Thanh A; Kamegashira A; Meshkova R; Vitchuk A; Bauer A; Grattan C; Staubach P; Bouillet L; Giménez-Arnau AM; Maurer M; Weller K
    J Allergy Clin Immunol Pract; 2023 Feb; 11(2):610-620.e5. PubMed ID: 36481420
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical characteristics and management of chronic spontaneous urticaria in patients refractory to H
    Chu CY; Al Hammadi A; Agmon-Levin N; Atakan N; Farag A; Arnaout RK; Kannenberg S; Kulthanan K; Mubarak A; Zaitoun F; Crowe S; Malfait S; Cooke K; Dekker EL
    World Allergy Organ J; 2020 Apr; 13(4):100117. PubMed ID: 32382379
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihistamine-resistant chronic spontaneous urticaria: 1-year data from the AWARE study.
    Maurer M; Raap U; Staubach P; Richter-Huhn G; Bauer A; Oppel EM; Hillen U; Baeumer D; Reinhardt M; Chapman-Rothe N
    Clin Exp Allergy; 2019 May; 49(5):655-662. PubMed ID: 30415478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The burden of chronic spontaneous urticaria is substantial: Real-world evidence from ASSURE-CSU.
    Maurer M; Abuzakouk M; Bérard F; Canonica W; Oude Elberink H; Giménez-Arnau A; Grattan C; Hollis K; Knulst A; Lacour JP; Lynde C; Marsland A; McBride D; Nakonechna A; Ortiz de Frutos J; Proctor C; Sussman G; Sweeney C; Tian H; Weller K; Wolin D; Balp MM
    Allergy; 2017 Dec; 72(12):2005-2016. PubMed ID: 28543019
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Validation of the Turkish version of the Urticaria Control Test: Correlation with other tools and comparison between spontaneous and inducible chronic urticaria.
    Kocatürk E; Kızıltaç U; Can P; Öztaş Kara R; Erdem T; Kızıltaç K; Sahillioğlu N; Gelincik A; Maurer M; Weller K
    World Allergy Organ J; 2019; 12(1):100009. PubMed ID: 30937134
    [TBL] [Abstract][Full Text] [Related]  

  • 7. H1-antihistamine-refractory chronic spontaneous urticaria: it's worse than we thought - first results of the multicenter real-life AWARE study.
    Maurer M; Staubach P; Raap U; Richter-Huhn G; Bauer A; Ruëff F; Jakob T; Yazdi AS; Mahler V; Wagner N; Lippert U; Hillen U; Schwinn A; Pawlak M; Behnke N; Chaouche K; Chapman-Rothe N
    Clin Exp Allergy; 2017 May; 47(5):684-692. PubMed ID: 28160338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chronic urticaria treatment patterns and changes in quality of life: AWARE study 2-year results.
    Maurer M; Giménez-Arnau A; Ensina LF; Chu CY; Jaumont X; Tassinari P
    World Allergy Organ J; 2020 Sep; 13(9):100460. PubMed ID: 32983330
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Angioedema in chronic spontaneous urticaria is underdiagnosed and has a substantial impact: Analyses from ASSURE-CSU.
    Sussman G; Abuzakouk M; Bérard F; Canonica W; Oude Elberink H; Giménez-Arnau A; Grattan C; Hollis K; Hunter S; Knulst A; Lacour JP; Lynde C; Marsland A; McBride D; Maurer M; Nakonechna A; Ortiz de Frutos J; Reynolds M; Sweeney C; Tian H; Weller K; Wolin D; Balp MM
    Allergy; 2018 Aug; 73(8):1724-1734. PubMed ID: 29460968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic spontaneous urticaria activity, impact and control as well as their changes are strongly linked, and these links are not affected by angioedema or comorbid inducible urticaria - Results from the validation of the Polish Urticaria Control Test.
    Brzoza Z; Badura-Brzoza K; Maurer M; Hawro T; Weller K
    World Allergy Organ J; 2022 Mar; 15(3):100635. PubMed ID: 35399816
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Real-world safety and effectiveness of omalizumab in Japanese patients with chronic spontaneous urticaria: A post-marketing surveillance study.
    Hide M; Fukunaga A; Suzuki T; Nakamura N; Kimura M; Sasajima T; Kiriyama J; Igarashi A
    Allergol Int; 2023 Apr; 72(2):286-296. PubMed ID: 36272899
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Socio-economic burden and resource utilisation in Italian patients with chronic urticaria: 2-year data from the AWARE study.
    Rossi O; Piccirillo A; Iemoli E; Patrizi A; Stingeni L; Calvieri S; Gola M; Dapavo P; Cristaudo A; Zichichi L; Losappio L; Saccheri F; Pastorello EA
    World Allergy Organ J; 2020 Dec; 13(12):100470. PubMed ID: 33343800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Health care burden and treatment patterns in commercially insured children with chronic idiopathic/spontaneous urticaria: A real-world study in the United States.
    Williams P; Kavati A; Pilon D; Xiao Y; Zhdanava M; Balp MM; Lefebvre P; Ortiz B; Hernandez-Trujillo V
    Allergy Asthma Proc; 2018 May; 39(3):201-211. PubMed ID: 29514728
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The burden of chronic spontaneous urticaria: unsatisfactory treatment and healthcare resource utilization in France (the ASSURE-CSU study).
    Lacour JP; Khemis A; Giordano-Labadie F; Martin L; Staumont-Salle D; Hacard F; Tian H; McBride D; Hollis K; Hunter S; Martin L; Lamirand A; Le Guen S; Balp MM; Berard F
    Eur J Dermatol; 2018 Dec; 28(6):795-802. PubMed ID: 30698148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Validity and responsiveness of the Urticaria Activity and Impact Measure: A new patient-reported tool.
    Maurer M; Mathias SD; Crosby RD; Rajput Y; Zazzali JL
    Ann Allergy Asthma Immunol; 2018 Jun; 120(6):641-647. PubMed ID: 29567359
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Omalizumab versus cyclosporin-A for the treatment of chronic spontaneous urticaria: can we define better-responding endotypes?
    Kocatürk E; Başkan EB; Küçük ÖS; Özdemir M; Örnek S; Can PK; Haşal E; Engin B; Atakan N; Alpsoy E
    An Bras Dermatol; 2022; 97(5):592-600. PubMed ID: 35853771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antihistamine-resistant chronic spontaneous urticaria remains undertreated: 2-year data from the AWARE study.
    Maurer M; Costa C; Gimenez Arnau A; Guillet G; Labrador-Horrillo M; Lapeere H; Meshkova R; Savic S; Chapman-Rothe N
    Clin Exp Allergy; 2020 Oct; 50(10):1166-1175. PubMed ID: 32735720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A genome-wide association study of chronic spontaneous urticaria risk and heterogeneity.
    Chang D; Hammer C; Holweg CTJ; Selvaraj S; Rathore N; McCarthy MI; Yaspan BL; Choy DF
    J Allergy Clin Immunol; 2023 May; 151(5):1351-1356. PubMed ID: 36343773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic Spontaneous Urticaria in Belgium: Deciphering the Clinical Profile and Treatment of Patients Visiting an Urban City Immunology Department.
    Mostmans Y; Richert B; De Maertelaer V; Saidi I; Benslimane A; Thi Thanh TT; Corazza F; Michel O
    Dermatology; 2023; 239(6):926-936. PubMed ID: 37634502
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Omalizumab in patients with chronic spontaneous urticaria nonresponsive to H1-antihistamine treatment: results of the phase IV open-label SUNRISE study.
    Bérard F; Ferrier Le Bouedec MC; Bouillet L; Reguiai Z; Barbaud A; Cambazard F; Milpied B; Pelvet B; Kasujee I; Gharbi H; Lacour JP
    Br J Dermatol; 2019 Jan; 180(1):56-66. PubMed ID: 29927483
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.